Quantitative Analysis of FFPE Tumor for Biomarker Trials
Thu, Jun 4, 2015 | 4:00 PM - 5:00 PM BST
Join our guest speaker, Professor Manuel Salto-Tellez, a leading pathologist in the area of molecular and digital pathology to hear about the key advantages of an automated approach to tumor detection and quantification versus the traditional manual methods.
Professor Manuel Salto-Tellez will discuss the importance of tumor evaluation in molecular pathology and the potential impact of TissueMark in biomarker discovery, validation and clinical trials. Professor Peter Hamilton, PathXL’s Vice President for Research and Development will join Professor Salto-Tellez for a Q&A session at the end of the webinar.
Find out more and download our brochure here: http://www.pathxl.com/digital-pathology/tissuemark